Skip to main content

University of Michigan

University of Michigan
Ann Arbor, Michigan
SOURCE: SPIROMICS Study of Early COPD Progression is looking for current and former cigarette smokers between 30 and 55 years old to participate in a research study on early signs of lung disease. Most studies of lung disease and Chronic Obstructive Pulmonary Disease (COPD) involve older people. This 5-year study in 12 cities across the U.S. will help us better understand COPD in younger people. You do not need a COPD diagnosis to join.

The SOURCE Study is not yet active in Ann Arbor but will begin enrolling participants in Fall 2021. Please check back soon.

Study Site Location

Michigan Medicine
Michigan Clinical Research Unit (MCRU)
Frankel Cardiovascular Center, Floor 1
1500 East Medical Center Drive
Ann Arbor, MI 48130

(734) 647-6399 ccutlip@med.umich.edu
SOURCE study principal investigator MeiLan Han, MD, MS
MeiLan Han, MD, MS
Principal Investigator
The COVID-19 pandemic has made the world more aware of the importance of lung health than ever. This study offers participants an opportunity to better understand their own lung health and for researchers to better understand factors that contribute to lung health and disease.
Crystal Cutlip Portrait
Crystal Cutlip
Clinical Research Coordinator
(734)647-6399
false

Are you eligible to join?

Current and former cigarette smokers are eligible. No COPD diagnosis is necessary. Answer the screening questions by entering your age and the numbers of years smoked. If you are eligible, you’ll be asked for your contact information. By submitting your contact information you’re agreeing to be contacted about this study.

Individuals between the ages of 30 and 55 who are current or former cigarette smokers may qualify for this study on early COPD.